Significant decrease of the enhancement/neutralization index in HIV patients during highly active antiretroviral therapy (HAART). (Q45105022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Significant decrease of the enhancement/neutralization index in HIV patients during highly active antiretroviral therapy (HAART) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Zoltan Prohaszka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Dénes Bánhegyi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Ferenc D Tóth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Anna Horváth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Zoltán Beck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

József Kónya

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

George Füst

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

25-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Predominance of detrimental humoral immune responses to HIV-1 in AIDS patients with CD4 lymphocyte counts less than 400/mm3.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeficiency virus during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Antibodies raised to short synthetic peptides with sequences derived from HIV-1 SF2 gp120 can both neutralize and enhance HIV-1 SF13: a later variant isolated from the same host.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

[Effect of highly active antiretroviral therapy (HAART) on hypergammaglobulinemia in HIV infected patients]

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900106-8

7 January 2021

10.1016/S0165-2478(03)00106-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946861%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference